Peter Kenneth Gillman

Summary

Affiliation: Pioneer Valley Private Hospital
Country: Australia

Publications

  1. ncbi Mirtazapine: not a dual action antidepressant?
    P Ken Gillman
    Aust N Z J Psychiatry 38:266-7. 2004
  2. ncbi Misleading cases
    P Ken Gillman
    J Am Med Dir Assoc 6:422-3; author reply 423-5. 2005
  3. ncbi A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action
    P Ken Gillman
    Department of Clinical Neuropharmacology, Pioneer Valley Private Hospital, North Mackay, Queensland, Australia
    Biol Psychiatry 59:1046-51. 2006
  4. ncbi Tricyclic antidepressant pharmacology and therapeutic drug interactions updated
    P K Gillman
    PsychoTropical Research, Bucasia, Queensland, Australia
    Br J Pharmacol 151:737-48. 2007
  5. ncbi Advances pertaining to the pharmacology and interactions of irreversible nonselective monoamine oxidase inhibitors
    Peter Kenneth Gillman
    MRCPsych, PO Box 86, Bucasia, Queensland 4750, Australia
    J Clin Psychopharmacol 31:66-74. 2011
  6. ncbi Neuroleptic malignant syndrome: mechanisms, interactions, and causality
    P Ken Gillman
    PsychoTropical Research, Queensland, Australia
    Mov Disord 25:1780-90. 2010
  7. ncbi CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity
    P Ken Gillman
    PsychoTropical Research, Bucasia, Queensland, Australia
    J Psychopharmacol 25:429-36. 2011
  8. ncbi A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status
    P Ken Gillman
    Pioneer Valley Private Hospital, Australia
    Hum Psychopharmacol 21:117-25. 2006
  9. ncbi Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity
    P K Gillman
    Pioneer Valley Private Hospital, Mackay, Queensland, Australia
    Br J Anaesth 95:434-41. 2005
  10. ncbi Triptans, serotonin agonists, and serotonin syndrome (serotonin toxicity): a review
    P Ken Gillman
    Bucasia, Queensland, Australia
    Headache 50:264-72. 2010

Collaborators

Detail Information

Publications19

  1. ncbi Mirtazapine: not a dual action antidepressant?
    P Ken Gillman
    Aust N Z J Psychiatry 38:266-7. 2004
  2. ncbi Misleading cases
    P Ken Gillman
    J Am Med Dir Assoc 6:422-3; author reply 423-5. 2005
  3. ncbi A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action
    P Ken Gillman
    Department of Clinical Neuropharmacology, Pioneer Valley Private Hospital, North Mackay, Queensland, Australia
    Biol Psychiatry 59:1046-51. 2006
    ..Tricyclic antidepressants (other than clomipramine and imipramine) do not precipitate serotonin toxicity and might not elevate serotonin or have a dual action, as has been assumed...
  4. ncbi Tricyclic antidepressant pharmacology and therapeutic drug interactions updated
    P K Gillman
    PsychoTropical Research, Bucasia, Queensland, Australia
    Br J Pharmacol 151:737-48. 2007
    ..Standard texts (e.g. the British National Formulary) and treatment guidelines would benefit by taking account of these new data and understandings...
  5. ncbi Advances pertaining to the pharmacology and interactions of irreversible nonselective monoamine oxidase inhibitors
    Peter Kenneth Gillman
    MRCPsych, PO Box 86, Bucasia, Queensland 4750, Australia
    J Clin Psychopharmacol 31:66-74. 2011
    ..Monoamine oxidase inhibitors are not used to an extent proportionate with their benefits; medical texts and doctors' knowledge require a major update to reflect the evidence of recent advances...
  6. ncbi Neuroleptic malignant syndrome: mechanisms, interactions, and causality
    P Ken Gillman
    PsychoTropical Research, Queensland, Australia
    Mov Disord 25:1780-90. 2010
    ..involving compounding interactions, are required to precipitate hyperthermia. The application of the Hill criteria clearly supports causality for drugs inducing both MH and ST but do not support causality for NMS...
  7. ncbi CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity
    P Ken Gillman
    PsychoTropical Research, Bucasia, Queensland, Australia
    J Psychopharmacol 25:429-36. 2011
    ..It seems that all proposed uses of methylene blue entail levels that block monoamine oxidase, so cessation of serotonin reuptake inhibitors should be very carefully considered before using methylene blue...
  8. ncbi A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status
    P Ken Gillman
    Pioneer Valley Private Hospital, Australia
    Hum Psychopharmacol 21:117-25. 2006
    ..Mirtazapine has no demonstrable serotonergic effects in humans and there is insufficient evidence to designate it as a dual-action drug...
  9. ncbi Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity
    P K Gillman
    Pioneer Valley Private Hospital, Mackay, Queensland, Australia
    Br J Anaesth 95:434-41. 2005
    ..Morphine, codeine, oxycodone and buprenorphine are known not to be SRIs, and do not precipitate serotonin toxicity with MAOIs...
  10. ncbi Triptans, serotonin agonists, and serotonin syndrome (serotonin toxicity): a review
    P Ken Gillman
    Bucasia, Queensland, Australia
    Headache 50:264-72. 2010
    ..The misunderstandings about SS exhibited by the FDA, and shared by the UK Medicines and Healthcare products Regulatory Agency (in relation to methylene blue), are an important issue with wide ramifications...
  11. ncbi Linezolid and serotonin toxicity
    P Ken Gillman
    Clin Infect Dis 37:1274-5. 2003
  12. ncbi The spectrum concept of serotonin toxicity
    P Ken Gillman
    Pain Med 5:231-2; author reply 233. 2004
  13. ncbi Extracting value from case reports: lessons from serotonin toxicity
    P Ken Gillman
    Anaesthesia 61:419-22. 2006
  14. ncbi Serotonin toxicity associated with the use of linezolid: a review of postmarketing data
    Kenneth R Lawrence
    Tufts New England Medical Center, Department of Pharmacy, Boston, Massachusetts 02111, USA
    Clin Infect Dis 42:1578-83. 2006
    ..The concomitant administration of nonselective MAO inhibitors or MAO-A inhibitors with drugs that increase serotonin concentrations is associated with serotonin toxicity...
  15. ncbi Comment on: Serotonin syndrome due to co-administration of linezolid and venlafaxine
    P Ken Gillman
    J Antimicrob Chemother 54:844-5. 2004
  16. ncbi Methylene blue is a potent monoamine oxidase inhibitor
    P Ken Gillman
    Can J Anaesth 55:311-2; author reply 312. 2008
  17. ncbi Making sense of serotonin toxicity reports, a comment on Chopra et Al. (World J Biol Psychiatry 2004, 5: 114-115)
    P Ken Gillman
    World J Biol Psychiatry 5:167-8. 2004
  18. ncbi Amitriptyline: dual-action antidepressant?
    P Ken Gillman
    J Clin Psychiatry 64:1391; author reply 1391-2. 2003
  19. ncbi Understanding toxidromes: serotonin toxicity: a commentary on Montanes-Rada et al
    P Ken Gillman
    J Clin Psychopharmacol 25:625-6. 2005